|
Delayed
Nasdaq
14:12:25 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 1.300 USD | +0.78% |
|
+13.04% | -76.01% |
| 08-14 | Exicure, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-30 | Exicure, Inc. Announces Board and Committee Changes, Effective June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EXICURE, INC. | Bio Therapeutic Drugs | +0.78% | +13.04% | -76.01% | -76.23% | -99.38% | 8.44M |  | | |
- Stock Market
- Stocks
- XCUR Stock
- Charts Exicure, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
